KINGDON CAPITAL MANAGEMENT L.L.C. 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-12 1:04 pm Purchase | 2025-09-30 | 13G | JASPER THERAPEUTICS INC NE JSPR | KINGDON CAPITAL MANAGEMENT L.L.C. | 1,324,845 4.700% | 559,845 (+73.18%) | Filing |
| 2025-07-11 12:30 pm Purchase | 2025-07-03 | 13G | JASPER THERAPEUTICS INC NE JSPR | KINGDON CAPITAL MANAGEMENT L.L.C. | 765,000 5.100% | 765,000 (New Position) | Filing |